Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
Completed · Phase 3
Conditions studied: Metastatic Cancer
In brief
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Radiosurgery may be able to deliver x-rays directly to the tumor and cause less damage to normal tissue. It is not yet known if radiosurgery is more effective with or without whole-brain radiation therapy in treating brain metastases. PURPOSE: Randomized phase III trial to compare the effectiveness of radiosurgery with or without whole-brain radiation therapy in treating patients who have brain metastases.
Key facts
- Study ID
- NCT00030628
- Run by
- Alliance for Clinical Trials in Oncology
- People needed
- 480
- Starts
- 2001-12-01
- Expected to finish
- 2014-10-01
- Last updated by the study team
- 2016-07-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of cerebral metastases meeting all of the following requirements:
- 1-3 de novo lesions
- Metastases must be from a histologically confirmed extracerebral primary site, another metastatic site, or from the metastatic brain lesion(s)
- Each lesion must be less than 3.0 cm by contrasted MRI of the brain
- Lesions must not be within 5 mm of optic chiasm or within the brainstem
- No primary germ cell tumor, small cell carcinoma, or lymphoma
- No leptomeningeal metastases
- Eligible for treatment with gamma knife or linear accelerator-based radiosurgery
- Performance status - ECOG 0-2
- Performance status - Zubrod 0-2
- Not pregnant
- Negative pregnancy test
- Fertile patients must use effective contraception
- Male patients must continue to use contraception for 3 months after the completion of radiotherapy
- No pacemaker or other MRI-incompatible metal in body
- No known allergy to gadolinium
- Deemed to be at low risk for recurrence from any prior malignancies
- At least 7 days since prior chemotherapy
- Concurrent hormonal agents allowed
- Concurrent steroids allowed
- No prior cranial radiotherapy
- No prior resection of cerebral metastasis
- Concurrent anticonvulsants allowed provided therapeutic serum/plasma level maintained before study intervention
Where it is running
- University of Alabama at Birmingham Comprehensive Cancer Center — Birmingham, Alabama, United States
- St. Joseph's Hospital and Medical Center — Phoenix, Arizona, United States
- Foundation for Cancer Research and Education — Phoenix, Arizona, United States
- Mount Diablo Regional Cancer Center — Concord, California, United States
- Sutter Cancer Center — Sacramento, California, United States
- UCSF Comprehensive Cancer Center — San Francisco, California, United States
- John Muir Comprehensive Cancer Center at John Muir Medical Center — Walnut Creek, California, United States
- University of Colorado Cancer Center at University of Colorado Health Sciences Center — Aurora, Colorado, United States
- Yale Comprehensive Cancer Center — New Haven, Connecticut, United States
- Shands Cancer Center at the University of Florida Health Science Center — Gainesville, Florida, United States
- University of Illinois Medical Center — Chicago, Illinois, United States
- Genesis Regional Cancer Center at Genesis Medical Center — Davenport, Iowa, United States
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center — Kansas City, Kansas, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland, United States
- Brigham and Women's Hospital — Boston, Massachusetts, United States
- Barbara Ann Karmanos Cancer Institute — Detroit, Michigan, United States
- Josephine Ford Cancer Center at Henry Ford Health System — Detroit, Michigan, United States
- Siteman Cancer Center at Barnes-Jewish Hospital — St Louis, Missouri, United States
- John F. Kennedy Medical Center — Edison, New Jersey, United States
- SUNY Upstate Medical University Hospital — Syracuse, New York, United States
- Blumenthal Cancer Center at Carolinas Medical Center — Charlotte, North Carolina, United States
- Carolina Neurosurgery and Spine Associates — Charlotte, North Carolina, United States
- American College of Surgeons Oncology Group — Durham, North Carolina, United States
- Duke Comprehensive Cancer Center — Durham, North Carolina, United States
- Comprehensive Cancer Center at Wake Forest University — Winston-Salem, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.